SECO 2023: Sleep disorders impact eye disease
Paul Chous, MA, OD, FAAO, shares key highlights from his 2023 SECO presentation looking at sleep disorders and how they play a role in eye disease.
SECO 2023: Learning about the lids
Mile Brujic, OD, shares highlights from his SECO 2023 presentation, "Learning about the Lid: Optimizing recognition, diagnosis, and treatment of Demodex blepharitis and blepharoptosis."
SECO 2023: Incorporating confocal scanning laser imaging in practice
Mile Brujic, OD, shares highlights from his SECO 2023 poster presentation on confocal scanning laser imaging and patient care.
SECO 2023: Keeping an eye on geographic atrophy
Mohammed Rafieetary, OD, shares key takeaways from his SECO 2023 presentation, "Advancing the understanding of geographic atrophy."
SECO 2023: Contact lenses for presbyopic patients
Milton M. Hom, OD, FAAO, FACAAI (Sc), shares key highlights from his portion of the "Presbyopia management panel," during SECO 2023 in Atlanta.
Digging into the 6-month first-in-human clinical trial data from SpyGlass Pharma
February 14th 2023Patrick Mooney, CEO of SpyGlass Pharma, sits down to discuss the 6-month first-in-human clinical trial data of their drug delivery platform with bimatoprost, which is implanted during routine cataract surgery.
Dompe's past developments, continual progress in NGF applications
Flavio Mantelli, MD, PhD, Chief Medical Officer at Dompé, shares about the company's role in nerve growth factor (NGF) applications in ophthalmic disease and other human indications.
G360 2023: The latest in IOLs: When and how to use them
Shan Lin, MD, gives key takeaways from his G360 presentation, "The latest in IOLs: When and how to use them?"